NCT06664333 Experiences Reported by Siblings of Children Hospitalized in the PICU
| NCT ID | NCT06664333 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Intensive Care Pediatric |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-01-21 |
| Primary Completion | 2027-12-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2025-01-21 with a primary completion date of 2027-12-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The care for a child in pediatric intensive care is recognized as a traumatic experience for the patient and their entourage. The needs and feelings of parents are relatively well supported in the literature. However, there is still too little data concerning siblings, who can nevertheless be impacted by this difficult life experience. The study consists of conducting two semi-structured interviews with siblings of children hospitalized in pediatric intensive care at Necker-Enfants Malades Hospital and Robert Debré Hospital. The first interview will take place during the stay in intensive care, the second one 1 month after discharge from pediatric intensive care.
Eligibility Criteria
Inclusion Criteria: * Children and adolescents aged 9 to 18 years * Whose sister or brother is hospitalized in pediatric intensive care at Necker-Enfants Malades hospital or Robert Debré hospital * Holders of parental authority and children or adolescents informed and consenting to participate in the study Exclusion Criteria: * Death of patients * Language barrier (French not mastered) * Inability to participate in a semi-structured interview (intellectual disability)
Contact & Investigator
Léo MD Berger, Doctor
PRINCIPAL INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Frequently Asked Questions
Who can join the NCT06664333 clinical trial?
This trial is open to participants of all sexes, aged 9 Years or older, up to 18 Years, studying Intensive Care Pediatric. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06664333 currently recruiting?
Yes, NCT06664333 is actively recruiting participants. Contact the research team at leo.berger@aphp.fr for enrollment information.
Where is the NCT06664333 trial being conducted?
This trial is being conducted at Paris, France, Paris, France.
Who is sponsoring the NCT06664333 clinical trial?
NCT06664333 is sponsored by Assistance Publique - Hôpitaux de Paris. The principal investigator is Léo MD Berger, Doctor at Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 20 participants.